Norofert (Romania) Performance
| NRF Stock | 3.60 0.01 0.28% |
The company secures a Beta (Market Risk) of -0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Norofert are expected to decrease at a much lower rate. During the bear market, Norofert is likely to outperform the market. At this point, Norofert SA has a negative expected return of -0.0515%. Please make sure to verify Norofert's daily balance of power, and the relationship between the skewness and day typical price , to decide if Norofert SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Norofert SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Norofert is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Norofert |
Norofert Relative Risk vs. Return Landscape
If you would invest 375.00 in Norofert SA on September 27, 2024 and sell it today you would lose (15.00) from holding Norofert SA or give up 4.0% of portfolio value over 90 days. Norofert SA is producing return of less than zero assuming 1.6392% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Norofert, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Norofert Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Norofert's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Norofert SA, and traders can use it to determine the average amount a Norofert's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0314
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NRF |
Estimated Market Risk
| 1.64 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Norofert is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Norofert by adding Norofert to a well-diversified portfolio.
Things to note about Norofert SA performance evaluation
Checking the ongoing alerts about Norofert for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Norofert SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Norofert SA generated a negative expected return over the last 90 days |
- Analyzing Norofert's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Norofert's stock is overvalued or undervalued compared to its peers.
- Examining Norofert's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Norofert's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Norofert's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Norofert's stock. These opinions can provide insight into Norofert's potential for growth and whether the stock is currently undervalued or overvalued.